Effects of citral, a naturally occurring antiadipogenic molecule, on an energy-intense diet model of obesity

Indian Journal of Pharmacology

Volumn 43, Issue 3, 2011, Pages 300-305

  Modak, Tamonud ^a   Mukhopadhaya, Abhilash ^a  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Citral; obesity; retinaldehyde; type 2 diabetes mellitus

Indexed keywords

CITRAL;

ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL SIZE; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MALE; METABOLISM; NONHUMAN; OBESITY; RAT; WEIGHT GAIN;

EID: 79958295653     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.81515     Document Type: Article

References (26)

1. Pi-Sunyer X. The medical risks of obesity. Postgrad Med 2009;121:21-33.
2. Isomma B. A major health hazard: The metabolic syndrome. Life Sci 2003;73:2395-2411.
3. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al.. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790-7.
4. World Health Organisation. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: World Health Organisation; 2000.
5. Wilding JP. Causes of obesity. Pract Diab Int 2001;18:288-91. (Pubitemid 33064624)
6. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53. (Pubitemid 38579764)
7. Hardeman W, Griffi n S, Johnston M, Kinmonth AL, Wareham NJ. Interventions to prevent weight gain: A systematic review of psychological models and behaviour change methods. Int J Obes Relat Metab Disord 2000;24:131-43. (Pubitemid 30107560)
8. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al.. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-62. (Pubitemid 41065039)
9. Ziouzenkova O, Orasanu G, Sharlach M, Akiyama TE, Berger JP, Viereck J, et al.. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 2007;13:695-702. (Pubitemid 46889756)
10. Carbajal D, Casaco A, Arruzazabala L, Gonzalez R, Tolon Z. Pharmacological study of Cymbopogon citrates leaves. J Ethnopharmacol 1989;25:103-7. (Pubitemid 19073016)
11. Scolnik MD, Servadio C, Abramovici A. Comparative study of experimentally induced benign and atypical hyperplasia in the ventral prostrate of different rat strains. J Androl 1994;15:287-97. (Pubitemid 24256641)
12. Vinitketkumnuen U, Puatanchokchai R, Kongtawelert P. Antimutagenicity of lemongrass (Cymbopogon citratus stapf) to various known mutagens in salmonella mutation assay. Mutat Res 1994;341:71-5. (Pubitemid 24324654)
13. Kikonyogo A, Abriola DP, Dryjanski M, Pietruszko R. Mechanism of inhibition of aldehyde dehydrogenase by citral, a retinoid antagonist. Eur J Biochem 1999;262:704-12. (Pubitemid 29291027)
14. Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science 1998;280:1371-4. (Pubitemid 28264817)
15. Rolls BJ, Rowe EA, Turner RC. Persistent obesity in rats following a period of consumption of a mixed, high-energy diet. J Physiol 1980;298:415-27. (Pubitemid 10111744)
16. Hughes PC, Tanner JM. A longitudinal study of the growth of the black hooded rat: Methods of measurement and rates of growth for skull, limbs, pelvis, nose-rump and tail lengths. J Anat 1970;106:349-70.
17. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol (Lond) 1949;109:1-9.
18. Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the effi cacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol 2009;15:3073-85.
19. Pitts GC, Bull LS. Exercise, dietary obesity, and growth in the rat. Am J Physiol 1977;232:R38-44. (Pubitemid 8041653)
20. Bunyan J, Murrell EA, Shah PP. The induction of obesity in rodents by means of monosodium glutamate. Br J Nutr 1976;35:25-39.
21. Zammit VA. Insulin stimulation of hepatic triacylglycerol secretion in the insulinreplete state: Implications for the etiology of peripheral insulin resistance. Ann N Y Acad Sci 2002;967:52-65. (Pubitemid 34721893)
22. Napoli JL. Retinoic acid: Its biosynthesis and metabolism. Prog Nucleic Acid Res Mol Biol 1999;63:139-88.
23. Duester G, Mic FA, Molotkov A. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specifi c metabolism to retinoic acid. Chem Biol Interact 2003;143-144:201-10. (Pubitemid 36246442)
24. Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, Uysal KT, et al.. Adipocyte/ macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 2005;1:107-19. (Pubitemid 43960591)
25. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001;7:947-53. (Pubitemid 32756433)
26. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al.. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288-95. (Pubitemid 35373562)